Fisher & Paykel Healthcare Corporation Limited
FSPKF
$16.35
-$0.5832-3.44%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -32.52% | -40.33% | -48.02% | -23.71% | -3.66% |
Total Depreciation and Amortization | 23.67% | 18.65% | 13.37% | 7.90% | 0.36% |
Total Amortization of Deferred Charges | 0.53% | 0.53% | 0.53% | -32.25% | -50.67% |
Total Other Non-Cash Items | 750.26% | 1,653.77% | 487.27% | 272.09% | 130.59% |
Change in Net Operating Assets | 239.71% | 166.96% | 116.96% | 112.59% | 109.06% |
Cash from Operations | 27.46% | 45.79% | 78.14% | 81.47% | 77.35% |
Capital Expenditure | 72.97% | 23.81% | -64.67% | -69.68% | -71.66% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -15.90% | -130.98% | -112.12% | -113.01% | -113.98% |
Cash from Investing | 67.49% | -20.06% | -3,453.92% | -1,485.81% | -851.89% |
Total Debt Issued | -59.19% | -5.75% | 118.62% | 259.77% | 814.29% |
Total Debt Repaid | -58.28% | -76.54% | -102.11% | -196.76% | -815.67% |
Issuance of Common Stock | 26.92% | 12.50% | 0.00% | -11.11% | -21.21% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | 6.43% | 20.77% | 32.05% | 35.54% | 39.60% |
Other Financing Activities | -68.06% | -30.62% | -6.07% | 14.60% | 35.07% |
Cash from Financing | -1,254.04% | -106.24% | 36.66% | 64.17% | 89.29% |
Foreign Exchange rate Adjustments | -7.06% | -41.16% | -15.19% | -113.20% | -145.86% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 1,104.64% | -55.93% | -212.87% | -551.45% | 112.04% |